Venture Capital

Top leaders from government, industry, and finance will convene to turn defense policy momentum into real-world speed and operational advantage at a critical summit.

A new US-Korean deal aims to solve the biggest hurdle for next-gen EV batteries: mass production. Can they win the high-stakes global battery race?

The Swedish freight-tech firm secures new funding for its SPAC merger, fueling a global push for its electric and autonomous trucking ecosystem.

Broadcom ships a revolutionary 2nm chip with 3.5D 'face-to-face' stacking, promising unprecedented power and efficiency for the next generation of AI.

Behind the success of iQIYI's new crime drama lies an AI powerhouse whose visual effects technology is quietly reshaping China's content landscape.

With new strategic leaders from Roche and capital markets, GATC Health aims to embed its AI risk prediction tool into pharma R&D and biotech investing.

With a massive new investment led by NewSpring, physician-led Honest Health is set to expand its mission of transforming healthcare from volume to value.

Defense startup NODA AI has secured $25M to build an AI 'brain' for military drones and robots, aiming to unify the future of algorithmic warfare.

With the hire of Greg Crescenzi, the famed academic repository signals a major strategic expansion to bridge the gap between scientific sharing and drug development.

The strategic acquisition unites two leaders in pipe rehabilitation, signaling a major consolidation in the booming market for fixing aging water infrastructure.

Banuba's new AI Talking Photo API promises to revolutionize video creation, but the rise of lifelike digital avatars also fuels a critical ethical debate.

New Energy New York is injecting capital into battery startups and SMEs to accelerate innovation and reshore manufacturing, a key move for U.S. energy security.

Robert Herjavec invests in AI firm Lovelytics, betting on the critical need for data infrastructure and aiming to scale the top Databricks partner.

With promising data for its oral STAT6 degrader and a cash runway into 2029, Kymera Therapeutics is poised to disrupt the injectable-dominated market.

With soaring sales for its rare obesity drug IMCIVREE, Rhythm Pharmaceuticals faces a critical March FDA decision that could unlock a massive new market.

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.

Semiconductor firm Aeluma will meet investors at the ROTH conference, betting its unique, scalable chip technology is the key to powering the future of AI and AR/VR.

Zoomcar's latest financing move involves complex warrants, raising questions about shareholder dilution and its strategy in India's car-sharing race.

Montréal startup JetScale AI lands an oversubscribed seed round for its AI platform that slashes cloud spending and energy waste in just minutes.

India's Tejas Networks will supply 5G radios to Japan's NEC, a deal signaling a major shift in global supply chains and a win for open network standards.